Literature DB >> 84963

Mucosal protection by prostaglandin E2.

C Johansson, B Kollberg, R Nordemar, S Bergström.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 84963     DOI： 10.1016/s0140-6736(79)90723-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  16, 16-dimethyl PGE2 fails to prevent ethanol-induced drop of gastric potential difference in man.

Authors:  P Müller; N Fischer; H Kather; B Simon
Journal:  Dig Dis Sci       Date:  1981-10       Impact factor: 3.199

2.  Prostaglandin E2 tablets prevent aspirin-induced blood loss in man.

Authors:  K Y Yik; A A Dreidger; W C Watson
Journal:  Dig Dis Sci       Date:  1982-11       Impact factor: 3.199

3.  Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

Authors:  M M Cohen; G Cheung; D M Lyster
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

4.  Prostanoids cytoprotection for maintaining remission in ulcerative colitis. Failure of 15(R), 15-methylprostaglandin E2.

Authors:  E Goldin; D Rachmilewitz
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

5.  Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study.

Authors:  D L Brand; W M Roufail; A B Thomson; E J Tapper
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

6.  The pathogenesis of the aspirin-related gastric lesion.

Authors:  J M Duggan
Journal:  J R Coll Physicians Lond       Date:  1981-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.